Skip to main content
Top
Published in: Journal of Clinical Immunology 7/2014

01-10-2014 | Astute Clinician Report

Atypical Severe Combined Immunodeficiency Caused by a Novel Homozygous Mutation In Rag1 Gene in a Girl who Presented with Pyoderma Gangrenosum: A Case Report and Literature Review

Authors: Turkan Patiroglu, H. Haluk Akar, Kimberly Gilmour, M. Akif Ozdemir, Shahnaz Bibi, Frances Henriquez, Siobhan O. Burns, Ekrem Unal

Published in: Journal of Clinical Immunology | Issue 7/2014

Login to get access

Abstract

Severe combined immunodeficiency (SCID) is a heterogeneous group of inherited defects involving the development of T- and/or B-lymphocytes. We report a female with atypical severe combined immunodeficiency caused by a novel homozygous mutation at cDNA position 2290 (c.2290C > T) in exon 2 of the RAG1 gene. The patient presented with bronchopneumonia, pyoderma gangrenosum (PG), pancytopenia and splenomegaly. She presented to us with pancytopenia and splenomegaly at the age of 11. Her condition was complicated by PG on left lower ankle at the age of 12. She experienced bronchopneumonia at the age of 15. She was diagnosed with RAG1 deficiency at the age of 16. Her immunological presentation included leucopenia and diminished number of B cells.
Literature
1.
go back to reference Fischer A. Have we seen the last variant of severe combined immunodeficiency? N Engl J Med. 2003;349:1789–92.PubMedCrossRef Fischer A. Have we seen the last variant of severe combined immunodeficiency? N Engl J Med. 2003;349:1789–92.PubMedCrossRef
2.
go back to reference Kelly BT, Tam JS, Verbsky JW, Routes JM. Screening for severe combined immunodeficiency in neonates. Clin Epidemiol. 2013;5:363–9.PubMedPubMedCentral Kelly BT, Tam JS, Verbsky JW, Routes JM. Screening for severe combined immunodeficiency in neonates. Clin Epidemiol. 2013;5:363–9.PubMedPubMedCentral
3.
go back to reference Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol. 2011;141:73–82.PubMed Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol. 2011;141:73–82.PubMed
4.
go back to reference Kutukculer N, Gulez N, Karaca NE, Aksu G, Berdeli A. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency. Ital J Pediatr. 2012;38:8. Kutukculer N, Gulez N, Karaca NE, Aksu G, Berdeli A. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency. Ital J Pediatr. 2012;38:8.
5.
go back to reference Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, et al. RAG mutations in human B cell-negative SCID. Science. 1996;274:97–9.PubMedCrossRef Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, et al. RAG mutations in human B cell-negative SCID. Science. 1996;274:97–9.PubMedCrossRef
6.
go back to reference Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130:378–87.PubMedCrossRef Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130:378–87.PubMedCrossRef
7.
go back to reference Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A. RAG-dependent primary immunodeficiencies. Hum Mutat. 2006;27:1174–84.PubMedCrossRef Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A. RAG-dependent primary immunodeficiencies. Hum Mutat. 2006;27:1174–84.PubMedCrossRef
8.
go back to reference Niehues T, Perez-Becker R, Schuetz C. More than just SCID–The phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol. 2010;135:183–92.PubMedCrossRef Niehues T, Perez-Becker R, Schuetz C. More than just SCID–The phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol. 2010;135:183–92.PubMedCrossRef
9.
go back to reference Giblin W, Chatterji M, Westfield G, Masud T, Theisen B, Cheng HL, et al. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood. 2009;113:2965–75.PubMedCrossRefPubMedCentral Giblin W, Chatterji M, Westfield G, Masud T, Theisen B, Cheng HL, et al. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood. 2009;113:2965–75.PubMedCrossRefPubMedCentral
10.
go back to reference Villa A, Sobacchi C, Notarangelo LD, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97:81–8.PubMedCrossRef Villa A, Sobacchi C, Notarangelo LD, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97:81–8.PubMedCrossRef
11.
go back to reference Dalal I, Tasher D, Somech R, et al. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome. Clin Immunol. 2011;140:284–90.PubMedCrossRef Dalal I, Tasher D, Somech R, et al. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome. Clin Immunol. 2011;140:284–90.PubMedCrossRef
12.
go back to reference Zhang ZY, Zhao XD, Jiang LP, et al. Clinical characteristics and molecular analysis of three Chinese children with Omenn syndrome. Pediatr Allergy Immunol. 2011;22:482–7.PubMedCrossRef Zhang ZY, Zhao XD, Jiang LP, et al. Clinical characteristics and molecular analysis of three Chinese children with Omenn syndrome. Pediatr Allergy Immunol. 2011;22:482–7.PubMedCrossRef
13.
go back to reference Avila EM, Uzel G, Hsu A, et al. Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics. 2010;126:1248–52.CrossRef Avila EM, Uzel G, Hsu A, et al. Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics. 2010;126:1248–52.CrossRef
14.
go back to reference Schutz C, Niehues T, Ehl S, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency(CID). Autoimmun Rev. 2010;9:477–82.CrossRef Schutz C, Niehues T, Ehl S, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency(CID). Autoimmun Rev. 2010;9:477–82.CrossRef
15.
go back to reference Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2014;133:1099–108. Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2014;133:1099–108.
16.
go back to reference de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291–9.PubMedCrossRefPubMedCentral de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291–9.PubMedCrossRefPubMedCentral
17.
go back to reference Kuijpers TW, Ijspeert H, van Leeuwen EM, Jansen MH, Hazenberg MD, Weijer KC, et al. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117:5892–6.PubMedCrossRef Kuijpers TW, Ijspeert H, van Leeuwen EM, Jansen MH, Hazenberg MD, Weijer KC, et al. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117:5892–6.PubMedCrossRef
18.
go back to reference Henderson LA, Frugoni F, Hopkins G, de Boer H, Pai SY, Lee YN, et al. Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity. J Allergy Clin Immunol. 2013;132:969–71.PubMedCrossRef Henderson LA, Frugoni F, Hopkins G, de Boer H, Pai SY, Lee YN, et al. Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity. J Allergy Clin Immunol. 2013;132:969–71.PubMedCrossRef
19.
go back to reference De Ravin SS, Cowen EW, Zarember KA, Whiting-Theobald NL, Kuhns DB, Sandler NG, et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood. 2010;116:1263–71.PubMedCrossRefPubMedCentral De Ravin SS, Cowen EW, Zarember KA, Whiting-Theobald NL, Kuhns DB, Sandler NG, et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood. 2010;116:1263–71.PubMedCrossRefPubMedCentral
20.
go back to reference Satoh M, Yamamoto T. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases. J Dermatol. 2013;40:840–3.PubMed Satoh M, Yamamoto T. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases. J Dermatol. 2013;40:840–3.PubMed
21.
go back to reference Löhrer R, Eming R, Wolfrum N, Krieg T, Eming SA. Autoinflammatory diseases as cause of wound healing defects. Hautarzt. 2011;62:524–33.PubMedCrossRef Löhrer R, Eming R, Wolfrum N, Krieg T, Eming SA. Autoinflammatory diseases as cause of wound healing defects. Hautarzt. 2011;62:524–33.PubMedCrossRef
Metadata
Title
Atypical Severe Combined Immunodeficiency Caused by a Novel Homozygous Mutation In Rag1 Gene in a Girl who Presented with Pyoderma Gangrenosum: A Case Report and Literature Review
Authors
Turkan Patiroglu
H. Haluk Akar
Kimberly Gilmour
M. Akif Ozdemir
Shahnaz Bibi
Frances Henriquez
Siobhan O. Burns
Ekrem Unal
Publication date
01-10-2014
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0077-5

Other articles of this Issue 7/2014

Journal of Clinical Immunology 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.